Caribbean 360 is reporting that Cuba’s Center of Molecular Immunology and New York’s Roswell Park Cancer Institute, have signed an agreement to export a therapeutic vaccine, Cimivax, against lung cancer developed in Cuba to the United States.
Cimivax was created in Cuba in 2011 after 15 years of research with patent rights worldwide. The vaccine reportedly doubles as a treatment for lung cancer.
The agreement came out of a trade mission led by New York Governor Andrew Cuomo. “The agreement will allow us to limit ourselves to clinical trials of the vaccine when we get to New York,” said Candace Johnson, the director of the Roswell Park Cancer Institute .
Read more at Caribbean 360.